drugset / Trial / NCT04371523
Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The objectives of PROVIDE are to: 1. Determine if prophylactic once weekly hydroxychloroquine reduces the incidence of conversion from SARS-2-CoVnasopharyngeal swab negative to positive 2. To determine if weekly prophylactic hydroxychloroquine reduced the severity of COVID-19 symptoms 3. To determine the safety of taking weekly prophylactic hydroxychloroquine
Timeline
- Start
- 2020-05-01
- Primary completion
- 2020-07-31
- Completion
- 2020-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxychloroquine | Small molecule | 400 mg | Oral |